MDNCMedinotec Inc.
Health Care
Research and Development Expense revised up 200.0% for Q1 2025
This is the 9th largest revision in MDNC's history.
Research and Development Expense
Q1 2025
As reported
-$49KRestated
$49K200.0%
Verify against SEC filingsShow
As reported-$49K
Accepted 2025-07-160001663577-25-000240
Restated$49K
Accepted 2026-07-090001663577-26-000202
ResearchAndDevelopment · reported 2 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get an alert the next time MDNC — or any company on your watchlist — restates a number. Every alert lands with the diff and its source filing.